ADMA Biologics Inc — 貸借対照表 (NASDAQ:ADMA) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 207.67 M276.25 M348.46 M329.18 M488.68 M624.24 M 負債合計 119.42 M135.08 M196.49 M193.98 M139.66 M146.92 M 純資産合計 88.25 M141.17 M151.97 M135.21 M349.02 M477.32 M 負債および純資産合計 207.67 M276.25 M348.46 M329.18 M488.68 M624.24 M 有利子負債合計 92.97 M94.87 M142.83 M130.59 M72.34 M72.14 M 純負債 -44.19 M-48.76 M-87.73 M-45.98 M-97.25 M-11.65 M

ニュース

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Is ADMA Poised for Margin Growth and Supply Expansion in 2026?

Adma Biologics (ADMA) Laps the Stock Market: Here's Why

ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA)

Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?

NVO Launches Wegovy Subscription Plan, Boosts Access, Stock Up

Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio

Incyte Reports Strong 54-Week Data From Late-Stage Skin Disorder Study

ADMA Biologics: Differentiated Plasma Approach With Asymmetric Upside Potential (Upgrade)

Novartis Bolsters Immunology Pipeline With Excellergy Deal

Novo Nordisk's Awiqli Gets FDA Approval for Type II Diabetes

KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate